ARBK1_HUMAN - dbPTM
ARBK1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ARBK1_HUMAN
UniProt AC P25098
Protein Name Beta-adrenergic receptor kinase 1
Gene Name GRK2 {ECO:0000312|HGNC:HGNC:289}
Organism Homo sapiens (Human).
Sequence Length 689
Subcellular Localization Cytoplasm . Cell membrane .
Protein Description Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors, probably inducing a desensitization of them. Key regulator of LPAR1 signaling. Competes with RALA for binding to LPAR1 thus affecting the signaling properties of the receptor. Desensitizes LPAR1 and LPAR2 in a phosphorylation-independent manner. [PubMed: 19306925]
Protein Sequence MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQQLVQRVPKMKNKPRSPVVELSKVPLVQRGSANGL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADLEAVLA
------CCHHHHHHH
30.05-
13PhosphorylationAVLADVSYLMAMEKS
HHHHHHHHHHHHHHC
10.5916725308
19UbiquitinationSYLMAMEKSKATPAA
HHHHHHHHCCCCHHH
44.1417006543
21UbiquitinationLMAMEKSKATPAARA
HHHHHHCCCCHHHHH
68.3117006543
29PhosphorylationATPAARASKKILLPE
CCHHHHHCCHHHCCC
29.0022817900
30UbiquitinationTPAARASKKILLPEP
CHHHHHCCHHHCCCH
42.7317006543
31UbiquitinationPAARASKKILLPEPS
HHHHHCCHHHCCCHH
35.7717006543
38PhosphorylationKILLPEPSIRSVMQK
HHHCCCHHHHHHHHH
29.0428450419
41PhosphorylationLPEPSIRSVMQKYLE
CCCHHHHHHHHHHHH
21.9223090842
45UbiquitinationSIRSVMQKYLEDRGE
HHHHHHHHHHHHCCC
33.44-
50MethylationMQKYLEDRGEVTFEK
HHHHHHHCCCCCHHH
33.52-
54PhosphorylationLEDRGEVTFEKIFSQ
HHHCCCCCHHHHHHH
23.0623090842
57UbiquitinationRGEVTFEKIFSQKLG
CCCCCHHHHHHHHHH
44.8821890473
62UbiquitinationFEKIFSQKLGYLLFR
HHHHHHHHHHHHHHH
42.5621890473
86PhosphorylationARPLVEFYEEIKKYE
HHHHHHHHHHHHHHH
10.1116725308
92PhosphorylationFYEEIKKYEKLETEE
HHHHHHHHHCCCCHH
17.1916725308
94UbiquitinationEEIKKYEKLETEEER
HHHHHHHCCCCHHHH
48.83-
115UbiquitinationIFDSYIMKELLACSH
HHHHHHHHHHHHCCC
35.33-
126UbiquitinationACSHPFSKSATEHVQ
HCCCCCCHHHHHHHH
44.48-
138UbiquitinationHVQGHLGKKQVPPDL
HHHHCCCCCCCCHHH
46.52-
139UbiquitinationVQGHLGKKQVPPDLF
HHHCCCCCCCCHHHH
55.52-
164UbiquitinationLRGDVFQKFIESDKF
CCCCHHHHHHHCCCC
36.52-
164AcetylationLRGDVFQKFIESDKF
CCCCHHHHHHHCCCC
36.5226822725
170UbiquitinationQKFIESDKFTRFCQW
HHHHHCCCCCEECCC
58.8921890473
206PhosphorylationRGGFGEVYGCRKADT
CCCCCCCCCCCCCCC
13.25-
213PhosphorylationYGCRKADTGKMYAMK
CCCCCCCCCCEEEEH
43.4922964224
215UbiquitinationCRKADTGKMYAMKCL
CCCCCCCCEEEEHHH
30.72-
220UbiquitinationTGKMYAMKCLDKKRI
CCCEEEEHHHCHHHC
24.39-
230UbiquitinationDKKRIKMKQGETLAL
CHHHCCCCCCCEEEE
50.58-
247PhosphorylationRIMLSLVSTGDCPFI
HHHHHHHCCCCCCEE
31.7822817900
248PhosphorylationIMLSLVSTGDCPFIV
HHHHHHCCCCCCEEE
29.5622817900
263PhosphorylationCMSYAFHTPDKLSFI
EEEHHCCCCCHHHHH
27.0822817900
319UbiquitinationFVVYRDLKPANILLD
EEEEECCCHHCEEEC
46.50-
344AcetylationGLACDFSKKKPHASV
CEECCCCCCCCCCCC
65.8825953088
344UbiquitinationGLACDFSKKKPHASV
CEECCCCCCCCCCCC
65.88-
345UbiquitinationLACDFSKKKPHASVG
EECCCCCCCCCCCCC
71.04-
346UbiquitinationACDFSKKKPHASVGT
ECCCCCCCCCCCCCC
45.85-
350PhosphorylationSKKKPHASVGTHGYM
CCCCCCCCCCCCCCC
20.3219369195
353PhosphorylationKPHASVGTHGYMAPE
CCCCCCCCCCCCCHH
15.2422817900
356PhosphorylationASVGTHGYMAPEVLQ
CCCCCCCCCCHHHHH
5.19-
389PhosphorylationFKLLRGHSPFRQHKT
HHHHHCCCHHHHCCC
28.6727067055
416PhosphorylationMAVELPDSFSPELRS
EEEECCCCCCHHHHH
26.19-
423PhosphorylationSFSPELRSLLEGLLQ
CCCHHHHHHHHHHHH
50.3521712546
448UbiquitinationGRGAQEVKESPFFRS
CCCCHHHHHCCCHHC
52.28-
487PhosphorylationADAFDIGSFDEEDTK
HHCCCCCCCCCCCCC
29.8329978859
493PhosphorylationGSFDEEDTKGIKLLD
CCCCCCCCCCEEEEC
34.1527732954
494UbiquitinationSFDEEDTKGIKLLDS
CCCCCCCCCEEEECC
71.59-
497UbiquitinationEEDTKGIKLLDSDQE
CCCCCCEEEECCCHH
52.22-
501PhosphorylationKGIKLLDSDQELYRN
CCEEEECCCHHHHHH
40.9627067055
506PhosphorylationLDSDQELYRNFPLTI
ECCCHHHHHHCCCCC
11.6229978859
545UbiquitinationARKKAKNKQLGHEED
HHHHHHHHCCCCHHH
46.31-
557UbiquitinationEEDYALGKDCIMHGY
HHHHHCCHHHHHHHH
50.72-
628UbiquitinationLLKIRGGKQFILQCD
EEEEECCCEEEEECC
44.88-
644UbiquitinationDPELVQWKKELRDAY
CHHHHHHHHHHHHHH
21.19-
644AcetylationDPELVQWKKELRDAY
CHHHHHHHHHHHHHH
21.1925953088
670PhosphorylationKMKNKPRSPVVELSK
HHCCCCCCCCEEHHC
30.4929255136
676PhosphorylationRSPVVELSKVPLVQR
CCCCEEHHCCCCEEC
20.3623927012
677UbiquitinationSPVVELSKVPLVQRG
CCCEEHHCCCCEECC
61.5721890473
683MethylationSKVPLVQRGSANGL-
HCCCCEECCCCCCC-
33.29-
685PhosphorylationVPLVQRGSANGL---
CCCEECCCCCCC---
22.2828355574

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
13YPhosphorylationKinaseSRCP12931
PSP
29SPhosphorylationKinasePRKCAP17252
GPS
29SPhosphorylationKinasePKCAP05696
PSP
29SPhosphorylationKinasePRKCDP09215
GPS
29SPhosphorylationKinasePRKCGP05129
GPS
86YPhosphorylationKinaseSRCP12931
PSP
92YPhosphorylationKinaseSRCP12931
PSP
670SPhosphorylationKinaseCDK2P24941
PSP
670SPhosphorylationKinaseMAPK-FAMILY-GPS
670SPhosphorylationKinaseMAPK_GROUP-PhosphoELM
685SPhosphorylationKinasePKA-FAMILY-GPS
685SPhosphorylationKinasePKA_GROUP-PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseMDM2Q00987
PMID:17006543

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ARBK1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ARBK1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
GNAQ_HUMANGNAQphysical
12885252
GNA15_HUMANGNA15physical
12885252
KPCB_HUMANPRKCBphysical
12679936
CNRG_HUMANPDE6Gphysical
12624098
SRC_HUMANSRCphysical
12624098
PHLP_HUMANPDCLphysical
10884381
PHOS_HUMANPDCphysical
10884381
OPSD_HUMANRHOphysical
10722682
FSHR_HUMANFSHRphysical
10379886
HDAC6_HUMANHDAC6physical
22193721
MDM2_HUMANMDM2physical
21081496
ARRB1_HUMANARRB1physical
21081496
GBB1_HUMANGNB1physical
17548351
GBB1_HUMANGNB1physical
10744734
CSEN_HUMANKCNIP3physical
17102134
ADRB2_HUMANADRB2physical
14654844
PEBP1_HUMANPEBP1physical
14654844
EPHA2_HUMANEPHA2physical
21988832
RGRF1_HUMANRASGRF1physical
21988832
GNAQ_HUMANGNAQphysical
21940795
RPGF3_MOUSERapgef3physical
20861385
HS90A_HUMANHSP90AA1physical
23455922
HS90B_HUMANHSP90AB1physical
23455922
ARBK2_HUMANADRBK2physical
23455922
ACACA_HUMANACACAphysical
23455922
SYNM_HUMANNARS2physical
26344197
ARBK2_HUMANADRBK2physical
28514442
GNAQ_HUMANGNAQphysical
10727532

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00171Adenosine triphosphate
Regulatory Network of ARBK1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350 AND THR-353, ANDMASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-670, AND MASSSPECTROMETRY.

TOP